All4NutraNo products in the cart.
All4NutraStartseite » Oral Excipients » Page 44
Abstract Gastrointestinal diseases offer a serious potential hazard to people's health due to their high morbidity, mortality, and low early...
PRESS RELEASE Oftringen (Switzerland), September 2023 – Manufacturers in the field of pharma and nutraceuticals can step into a new...
Solid dispersions (SDs) possess the potential to enhance the bioavailability of insoluble active pharmaceutical ingredients (APIs) by effectively converting them...
Extended-release tablets, also known as sustained-release, controlled-release, or time-release tablets, have become increasingly important in the healthcare sector due to...
Abstract The aim of the study was the preparation and comparison of two types of orodispersible gel films (ODF) by...
Oral administration is the most commonly used form of treatment due to its advantages, including high patient compliance, convenient administration,...
ABSTRACT Oral administration of medicine is one of the most common delivery routes still in use today. Various dosage forms...
Abstract Purpose Using a high level of mannitol as a diluent in oral formulations can potentially result in tablet defects (e.g.,...
Hydrophobic active pharmaceutical ingredients (APIs) are ubiquitous in the drug development pipeline, but their poor bioavailability often prevents their translation...
Amorphous solid dispersions (ASD) represent a viable formulation strategy to improve dissolution and bioavailability of poorly soluble drugs. Our study...
Copyright: PharmaExcipients AG